Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region

This study determined the prevalence and risk factors for diabetic peripheral neuropathy (DPN), painful DPN and diabetic foot ulceration (DFU) in patients with type 2 diabetes in secondary healthcare in Qatar, Kuwait and the Kingdom of Saudi Arabia.

[1]  R. DeFronzo,et al.  Insulin resistance limits corneal nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control , 2021, Journal of diabetes investigation.

[2]  A. Boulton,et al.  Diagnosis of Neuropathy and Risk Factors for Corneal Nerve Loss in Type 1 and Type 2 Diabetes: A Corneal Confocal Microscopy Study , 2020, Diabetes care.

[3]  R. Donn,et al.  Improvements in Diabetic Neuropathy and Nephropathy After Bariatric Surgery: a Prospective Cohort Study , 2020, Obesity Surgery.

[4]  M. Zirie,et al.  Prevalence and risk factors for diabetic neuropathy and painful diabetic neuropathy in primary and secondary healthcare in Qatar , 2020, Journal of diabetes investigation.

[5]  A. Boulton,et al.  Vitamin D deficiency is associated with painful diabetic neuropathy , 2020, Diabetes/metabolism research and reviews.

[6]  R. DeFronzo,et al.  Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study , 2020, BMJ open diabetes research & care.

[7]  R. Malik,et al.  Diagnosing peripheral neuropathy in South‐East Asia: A focus on diabetic neuropathy , 2020, Journal of diabetes investigation.

[8]  R. Forsythe,et al.  Definitions and criteria for diabetic foot disease , 2020, Diabetes/metabolism research and reviews.

[9]  M. Slevin,et al.  Prevalence and management of diabetic neuropathy in secondary care in Qatar , 2020, Diabetes/metabolism research and reviews.

[10]  M. Slevin,et al.  Prevalence and risk factors for painful diabetic neuropathy in secondary healthcare in Qatar , 2019, Journal of diabetes investigation.

[11]  6. Glycemic Targets: Standards of Medical Care in Diabetes—2019 , 2018, Diabetes Care.

[12]  W. Rathmann,et al.  General and Abdominal Obesity and Incident Distal Sensorimotor Polyneuropathy: Insights Into Inflammatory Biomarkers as Potential Mediators in the KORA F4/FF4 Cohort , 2018, Diabetes Care.

[13]  P. Guimarães,et al.  Corneal Nerve Migration Rate in a Healthy Control Population. , 2018, Optometry and vision science : official publication of the American Academy of Optometry.

[14]  Kiber Temesgen,et al.  Prevalence of Diabetic Foot Ulcer and Associated Factors among Adult Diabetic Patients Who Attend the Diabetic Follow-Up Clinic at the University of Gondar Referral Hospital, North West Ethiopia, 2016: Institutional-Based Cross-Sectional Study , 2017, Journal of diabetes research.

[15]  D. Armstrong,et al.  Diabetic Foot Ulcers and Their Recurrence. , 2017, The New England journal of medicine.

[16]  A. Terkawi,et al.  Development and validation of Arabic version of the douleur neuropathique 4 questionnaire , 2017, Saudi journal of anaesthesia.

[17]  Dalong Zhu,et al.  Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis† , 2017, Annals of medicine.

[18]  R. Freeman,et al.  Diabetic Neuropathy: A Position Statement by the American Diabetes Association , 2016, Diabetes Care.

[19]  R. Malik,et al.  NerveCheck: An inexpensive quantitative sensory testing device for patients with diabetic neuropathy. , 2016, Diabetes research and clinical practice.

[20]  Vittorio Cacciatori,et al.  Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Program. , 2015, Journal of diabetes and its complications.

[21]  S. L. Gong,et al.  Serum 25-hydroxyvitamin D levels and peripheral neuropathy in patients with type 2 diabetes: a systematic review and meta-analysis , 2015, Journal of Endocrinological Investigation.

[22]  Prabhu Dayal Sinwar,et al.  The diabetic foot management - recent advance. , 2015, International journal of surgery.

[23]  N. Abdella,et al.  Prospective Evaluation of the Effect of Short-Term Oral Vitamin D Supplementation on Peripheral Neuropathy in Type 2 Diabetes Mellitus , 2015, Medical Principles and Practice.

[24]  I. Petropoulos,et al.  The diagnostic accuracy of Neuropad® for assessing large and small fibre diabetic neuropathy , 2014, Diabetic medicine : a journal of the British Diabetic Association.

[25]  F. Hu,et al.  Prevalence and Correlates of Diabetic Peripheral Neuropathy in a Saudi Arabic Population: A Cross-Sectional Study , 2014, PloS one.

[26]  A. Abdulle,et al.  Prevalence and Determinants of Peripheral Neuropathy in Patients with Type 2 Diabetes Attending a Tertiary Care Center in the United Arab Emirates , 2014 .

[27]  A. Malik,et al.  25-Hydroxyvitamin D [25(OH)D] levels and diabetic foot ulcer: is there any relationship? , 2013, Diabetes & metabolic syndrome.

[28]  G. Marfia,et al.  Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy , 2012, Diabetic medicine : a journal of the British Diabetic Association.

[29]  R. Hu,et al.  High prevalence of diabetic neuropathy in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. , 2010, Diabetes research and clinical practice.

[30]  A. Karawagh,et al.  Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia , 2010, Current medical research and opinion.

[31]  F. Leonetti,et al.  Exercise training can modify the natural history of diabetic peripheral neuropathy. , 2005, Journal of diabetes and its complications.

[32]  A. Kocer,et al.  Prevalence of peripheral neuropathy in type 2 diabetic patients attending a diabetes center in Turkey. , 2004, Endocrine journal.

[33]  James W Mold,et al.  The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. , 2004, The Journal of the American Board of Family Practice.

[34]  C. Mathieu,et al.  NOD bone marrow-derived dendritic cells are modulated by analogs of 1,25-dihydroxyvitamin D3 , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[35]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .

[36]  M. Moser.  World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension-Do These Differ From the U.S. Recommendations? Which Guidelines Should the Practicing Physician Follow? , 1999, Journal of clinical hypertension.

[37]  Per Capita,et al.  About the authors , 1995, Machine Vision and Applications.

[38]  A. Veves,et al.  The Prediction of Diabetic Neuropathic Foot Ulceration Using Vibration Perception Thresholds: A prospective study , 1994, Diabetes Care.

[39]  P. Sönksen,et al.  A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population , 1993, Diabetologia.

[40]  C. Agardh,et al.  The association between clinical risk factors and outcome of diabetic foot ulcers. , 1992, Diabetes research and clinical practice.

[41]  R. Malik,et al.  Wherefore Art Thou, O Treatment for Diabetic Neuropathy? , 2016, International review of neurobiology.

[42]  A. Moghimbeigi,et al.  The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran. , 2013, Archives of Iranian medicine.

[43]  Who Consultation on Obesity.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation. , 2000, World Health Organization technical report series.